Pulmonary drug toxicity: radiologic and pathologic manifestations.
about
Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based ReviewStatin-induced lung injury: diagnostic clue and outcomeDiagnosis and management of drug-associated interstitial lung diseaseHigh-resolution CT of complications of idiopathic fibrotic lung diseaseProteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patientsSafety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease.Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung diseaseEfficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.Corticosteroid therapy against treatment-related pulmonary toxicities in patients with lung cancer.Nonspecific interstitial pneumonia: clinical associations and outcomesIdiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?Drug induced interstitial lung disease.Circulating KL-6 levels in patients with drug induced pneumonitis.Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Pulmonary function testing prior to hematopoietic stem cell transplantation.Pulmonary toxicity from novel antineoplastic agents.The role of pharmacoethnicity in the development of cytotoxic and molecular targeted drugs in oncologyThin-Section CT Characteristics and Longitudinal CT Follow-up of Chemotherapy Induced Interstitial Pneumonitis: A Retrospective Cohort Study.Diagnostic strategy in cancer patients with acute respiratory failure.Acute eosinophilic pneumonia caused by camostat mesilate: The first case reportReversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation.Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma.Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: high-resolution computed tomography findings.Corticosteroid-responsive pulmonary toxicity associated with fludarabine monophosphate: a case report.Pulmonary outcomes in survivors of childhood cancer: a systematic review.Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs.Cases non-specific interstitial pneumonia and hypersensitivity pneumonia: A new pathologic diagnosis or overlap syndrome.Amiodarone: review of pulmonary effects and toxicity.Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.Update on models of pulmonary fibrosis therapy for preclinical drug research.Hydrogels for controlled pulmonary delivery.Non-infectious respiratory disease in non-HIV immunocompromised patients.
P2860
Q26778887-1A4B80F0-BB92-41D6-A0D3-06DE71036710Q26822368-3975E03F-D20D-4B19-9E9A-7EBDFA2C3789Q28212076-C3693BE1-193A-4007-A181-3ECCB04CCFBBQ30462254-3240DF1E-E46D-4CFD-A101-0295CD93EFB0Q31026775-072DE593-AAA0-4964-8497-D05235398D61Q33424081-92405125-D651-47CB-A2D8-6A45277C8B7DQ33689926-ABA9FFAD-430C-44EC-BAA1-04B98059A0CEQ33938475-E332812F-9675-4617-AB9A-A4EF583C54CAQ33968014-BF33304E-F8F1-4456-9DA5-C5405C3F912BQ34258267-0C79C3AE-CDE2-4686-9FE2-96CA641851ADQ34537674-2A8B4E58-7349-40C6-AA76-7B428513E17BQ34635659-5D4CAEDD-BF80-4243-8302-970F718B6773Q34641494-B3D2E7D6-8B54-4A87-B223-08F5952008C2Q35535473-F7F2E1B8-0ED4-49EB-91D5-7C8394465816Q35570990-72710F14-B73A-4A7E-88F9-F3A4BBE61957Q35650402-B911C068-AC98-4B67-B18A-92627A5F6520Q35694784-4DD61596-412E-48D0-994C-330D07344DB4Q36011668-3934DF5E-11AF-41F7-A72D-19F8789957BAQ36314452-D266D29C-F5E0-478C-A525-F48593D74B96Q36463971-8F70492D-FEAB-4E53-92A4-EEFD50888B24Q36478155-C55A97E0-FBA3-467C-B1B1-16B597E59FB9Q36484636-5BC81AAB-8BD3-4DD1-9A63-8ABBDD8BCAC8Q37049265-5AEDAC8D-512D-4DD6-8B56-4B670D4B3968Q37063129-8C47480B-1FA9-4ED1-B467-F40770D678E0Q37098680-307FBB3E-C6BF-416A-B2BB-C9AD17CEB9BCQ37129982-A2BC5C55-3E15-45A2-9AB4-E8CCABE3A73EQ37193886-CFEBDA9E-0DF5-4F95-B5B3-035703BC9EE1Q37523788-C27EF821-90A5-4700-BA54-C76C98DDB298Q37576082-D375A448-7911-45E1-9196-3354663B67F6Q37576512-436C4AEB-75AA-442D-A45A-26BD563E6104Q37765549-343C1301-2223-4E87-B913-B31FDF987659Q37771879-90A3B2A2-504C-4579-8808-0C014D61FD96Q37931083-66D6BBE3-DC02-4BCC-BAAE-751B4EF57E7FQ37954366-35250B85-95AA-4C9E-9495-6F9426AE880CQ37973172-624A8999-9793-4CFF-AF7E-4E5A01D3FD5AQ38014958-E495D129-E8DE-44DB-86F0-F30E20FFA758Q38058679-9DFB465C-4BC6-4596-B3DE-136D4FEC48F7Q38088363-1686D352-D769-41EF-8AE7-7CE032E641EAQ38151737-9321D27C-51E8-4EB3-A0BE-641B3E3F185BQ38285559-BA26195D-E816-41EF-A115-1A2AD4EDA64B
P2860
Pulmonary drug toxicity: radiologic and pathologic manifestations.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@ast
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@en
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@nl
type
label
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@ast
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@en
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@nl
prefLabel
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@ast
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@en
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@nl
P2093
P1433
P1476
Pulmonary drug toxicity: radiologic and pathologic manifestations.
@en
P2093
P304
P356
10.1148/RADIOGRAPHICS.20.5.G00SE081245
P577
2000-09-01T00:00:00Z